CHENGDU KANGHONG PHARMACEUTICAL GROUP CO., LTD

Highlights Chengdu Kanghong Pharmaceutical Group Co., Ltd

Equities

002773

CNE1000020C4

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 07/06/2024 am IST			5-day change	1st Jan Change
22.71 ^CNY	-3.24%		+2.76%	+23.16%

04/06	Kanghong Pharmaceutical Gets Regulatory Nod for Pranoprofen Eye Drop	MT
22/05	Chengdu Kanghong Pharmaceutical Group Co., Ltd Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 28 May 2024	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Kanghong Pharmaceutical Gets Regulatory Nod for Pranoprofen Eye Drop	04/06	MT
Chengdu Kanghong Pharmaceutical Group Co., Ltd Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 28 May 2024	22/05	CI
Kanghong Pharmaceutical's Unit Gets Nod to Trial Macular Degeneration Drug	29/04	MT
Chengdu Kanghong Pharmaceutical Group Co., Ltd Proposes Final Cash Dividend for the Year 2023	25/04	CI
Chengdu Kanghong Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	24/04	CI
Chengdu Kanghong Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	24/04	CI
Kanghong Pharmaceutical's Mosapride Citrate Tablets Wins Centralized Procurement Bid	17/04	MT
Kanghong Pharmaceutical's Unit Gets Nod to Trial Psoriasis Drug	28/02	MT
Kanghong Pharmaceutical Gets Nod for Registration of Escitalopram Oxalate Tablets	12/12	MT
Kanghong Pharma's Aripiprazole Oral Solution Chosen for China's Centralized Drug Procurement	08/11	MT
Chengdu Kanghong Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	26/23/26	CI
Chengdu Kanghong Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	27/23/27	CI
Kanghong Pharma Gets Nod to Trial Antidepressant	20/23/20	MT
Kanghong Pharma Gets Continued Protection for Traditional Chinese Medicine	20/23/20	MT
Chengdu Kanghong Pharmaceutical Group Co., Ltd Announces Final Cash Dividend on Share A for 2022, Payable on June 6, 2023	31/23/31	CI
Chengdu Kanghong Pharmaceutical Group Co., Ltd Approves Cash Dividend for the Year 2022	25/23/25	CI
Chengdu Kanghong Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	27/23/27	CI
Kanghong Pharma Sees 121% Jump in 2022 Profit	19/23/19	MT
Kanghong Pharma Gets Marketing Nod in China for Antidepressant	23/22/23	MT
Chengdu Kanghong Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	27/22/27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Chengdu Kanghong Pharmaceutical Group Co., Ltd

Equities

002773

CNE1000020C4

Highlights

Filters